Quelch Darren R, Withey Sarah L, Nutt David J, Tyacke Robin J, Parker Christine A
Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK.
School of Physiology and Pharmacology, University of Bristol, Bristol BS8 1TD, UK.
Neuropharmacology. 2014 Oct;85(100):305-13. doi: 10.1016/j.neuropharm.2014.05.040. Epub 2014 Jun 6.
Various D2/3 receptor PET radioligands are sensitive to endogenous dopamine release in vivo. The Occupancy Model is generally used to interpret changes in binding observed in in vivo competition binding studies; an Internalisation Hypothesis may also contribute to these changes in signal. Extension of in vivo competition imaging to other receptor systems has been relatively unsuccessful. A greater understanding of the cellular processes underlying signal changes following endogenous neurotransmitter release may help translate this imaging paradigm to other receptor systems. To investigate the Internalisation Hypothesis we assessed the effects of different cellular environments, representative of those experienced by a receptor following agonist-induced internalisation, on the binding of three D2/3 PET ligands with previously reported sensitivities to endogenous dopamine in vivo, namely [3H]spiperone, [3H]raclopride and [3H]PhNO. Furthermore, we determined the contribution of each cellular compartment to total striatal binding for these D2/3 ligands. These studies suggest that sensitivity to endogenous dopamine release in vivo is related to a decrease in affinity in the endosomal environment compared with those found at the cell surface. In agreement with these findings we also demonstrate that ∼25% of total striatal binding for [3H]spiperone originates from sub-cellular, microsomal receptors, whereas for [3H]raclopride and [3H]PhNO, this fraction is lower, representing ∼14% and 17%, respectively. This pharmacological approach is fully translatable to other receptor systems. Assessment of affinity shifts in different cellular compartments may play a crucial role for understanding if a radioligand is sensitive to endogenous release in vivo, for not just the D2/3, but other receptor systems.
各种D2/3受体PET放射性配体在体内对内源性多巴胺释放敏感。占据模型通常用于解释体内竞争结合研究中观察到的结合变化;内化假说也可能导致这些信号变化。将体内竞争成像扩展到其他受体系统相对不太成功。对内源性神经递质释放后信号变化背后的细胞过程有更深入的了解,可能有助于将这种成像模式应用于其他受体系统。为了研究内化假说,我们评估了不同细胞环境(代表激动剂诱导内化后受体所处的环境)对三种D2/3 PET配体结合的影响,这三种配体在体内对内源性多巴胺具有先前报道的敏感性,即[3H]螺哌隆、[3H]雷氯必利和[3H]PhNO。此外,我们确定了每个细胞区室对这些D2/3配体总纹状体结合的贡献。这些研究表明,与细胞表面相比,体内对内源性多巴胺释放的敏感性与内体环境中亲和力的降低有关。与这些发现一致,我们还证明,[3H]螺哌隆总纹状体结合的约25%来自亚细胞微粒体受体,而对于[3H]雷氯必利和[3H]PhNO,这一比例较低,分别约为14%和17%。这种药理学方法完全可以应用于其他受体系统对于理解放射性配体是否在体内对内源性释放敏感,评估不同细胞区室中的亲和力变化可能起着关键作用,不仅对于D2/3受体,而且对于其他受体系统也是如此。